Fundraising Fox

Rain Therapeutics

Fremont, US · Founded 2017 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

Rain Therapeutics was founded in 2017 by Avanish Vellanki.

AV
Avanish VellankiinFounder

Investors · 3

Biotechnology Value FundreportedSan Francisco
Janus Henderson InvestorsreportedNew York
Samsara BioCapitalreportedPalo Alto

Reported raises · per SEC filings

Form D private placements

$92M disclosed across 3 rounds · 2017–2020

▶$72.6MraisedSep 2020 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tran NguyenDirector
  • Peter RadovichDirector
  • Gorjan HrustanovicDirector
  • Aaron DavisDirector
  • Franklin BergerDirector
  • Avanish VellankiExecutive Officer, Director
Offering amount
$72.6M
Amount sold
$72.6M
Minimum investment
$1
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.4MraisedMay 2018 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Avanish VellankiExecutive Officer
Offering amount
$18.4M
Amount sold
$18.4M
Minimum investment
$50K
First sale
Apr 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedDec 2017 · 24 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Avanish VellankiExecutive Officer
Offering amount
$1M
Amount sold
$1M
Minimum investment
$10K
Proceeds to insiders
$34K
First sale
Nov 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Rain Therapeutics scores $63m Series Bventurecapitaljournal.com · Sep 2020Rain Therapeutics Closes $63M Series B Funding | Precision Medicine Onlineprecisionmedicineonline.com · Sep 2020Busy Rain Therapeutics Licenses 2 Oncology Assets, Closes $63 Million Series B - BioSpacebiospace.com · Sep 2020Rain Therapeutics nets $18M to push lung cancer asset into phase 2 | Fierce Biotechfiercebiotech.com · May 2018Rain Therapeutics Closes on a $18.4 Million Series A - BioSpacebiospace.com · May 2018Rain Therapeutics - Wiki | Goldengolden.com

Frequently asked questions

Who founded Rain Therapeutics?
Rain Therapeutics was founded by Avanish Vellanki in 2017.
Who are Rain Therapeutics's investors?
Rain Therapeutics's investors include Biotechnology Value Fund, Janus Henderson Investors, Samsara BioCapital.
How much funding has Rain Therapeutics raised?
Rain Therapeutics has disclosed $92M raised across 3 rounds.
Where is Rain Therapeutics headquartered?
Rain Therapeutics is headquartered in Fremont, US.